z-logo
Premium
Effects of cessation of immunosuppression on skeleton reconstructed by vascularized bone allograft in rats
Author(s) -
Ikeda Keisuke,
Shigetomi Mitsunori,
Ihara Koichiro,
Tsubone Tetsu,
Hashimoto Takahiro,
Kawano Hiroo,
Sugiyama Toshihiro,
Kawai Shinya
Publication year - 2004
Publication title -
journal of orthopaedic research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.041
H-Index - 155
eISSN - 1554-527X
pISSN - 0736-0266
DOI - 10.1016/s0736-0266(03)00182-7
Subject(s) - immunosuppression , medicine , skeleton (computer programming) , transplantation , histocompatibility , bone mineral , surgery , urology , antigen , anatomy , immunology , osteoporosis , human leukocyte antigen
In the present study, we investigated the effects of cessation of immunosuppression on skeleton reconstructed by vascularized allogenic bone transplantation in a rat tibio–fibula graft model. Twelve‐week‐old male 25 Dark Agouti rats with the major histocompatibility antigen (MHC) RT1 a were used as donors and age‐matched male 25 Lewis rats with MHC RT1 1 were used as recipients. Among them, 20 rats were randomly allocated to 8‐week cyclosporine A (CsA) followed by 8‐week CsA vehicle group or continuous 16‐week CsA group. The remaining 5 rats received CsA for 8 weeks followed by no further treatment for next 40 weeks (long‐term observation group). In the CsA followed by vehicle group as well as the continuous CsA group, the structure of the reconstructed bones was maintained, though the transplanted bones in former group were found to be partly non‐vital. The CsA followed by vehicle group had higher bone mineral density of the transplanted bones and stronger strength of the reconstructed bones than the continuous CsA group. In the long‐term observation group, the structure of the reconstructed bones was still maintained and the transplanted bones were almost vital. These results suggest that long‐term strong immunosuppression may not be necessary for successful reconstruction of large bone defect by vascularized bone allograft. © 2003 Orthopaedic Research Society. Published by Elsevier Ltd. All rights reserved.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here